Monitoring of vasculogenesis-inhibiting activities in sewage effluents by using medaka embryos.
Environmental samples are known to be contaminated with complex chemicals such as estrogens, polycyclic aromatic hydrocarbons, and retinoids. These contaminants have potentially an adverse impact on survival of aquatic animals, because we found previously that medaka (Oryzias latipes) embryos are defective in the development of blood vessels and bones in the presence of these chemicals. Thus, it is important to test whether sewage effluents contain inhibitory activities against the embryonic development. To examine for such activity, medaka embryos were exposed for 48 h to extracts or freeze-evaporated concentrates of effluent samples collected from different municipal sewage treatment plants. We used the transgenic embryos that are hypersensitive to estrogens due to a high-level expression of estrogen receptor for detecting the total (sum of estrogenic and non-estrogenic) vessel-inhibiting activity. The embryos were specifically defective in blood-vessel formation in most effluent samples, showing the activities ranging from 3 to 30 ng of 17beta-estradiol equiv per liter. Detection limit of 17beta-estradiol was 10 ng per liter. For detection of the non-estrogenic vessel-inhibiting activity, we treated the transgenic embryos in the presence of an antiestrogen, tamoxifen, or used the wild-type embryos. The non-estrogenic activities were found in some (7 out of 18) effluents, ranging from half to all of the total activities. Our findings for the first time demonstrate the utility of the vascular assay for monitoring sewage effluents.
Sugise
Takeshi
T
Centerfor Gene Science, Hiroshima University, Kagamiyama 1-4-2, Higashihiroshima 739-8527, Japan.
Hayashida
Yasufumi
Y
Hanafusa
Takahiro
T
Nanjo
Emi
E
Yamashita
Ichiro
I
D000818:Animals; D030801:Animals, Genetically Modified; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D002947:Cities; D004625:Embryo, Nonmammalian / Q000187:drug effects* / Q000378:metabolism; D004958:Estradiol / Q000032:analysis / Q000378:metabolism; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D009990:Oryzias / Q000097:blood / Q000196:embryology / Q000235:genetics; D011960:Receptors, Estrogen / Q000187:drug effects* / Q000378:metabolism; D012722:Sewage / Q000032:analysis / Q000737:chemistry*; D013629:Tamoxifen / Q000494:pharmacology; D013997:Time Factors
D004967:Estrogens; D011960:Receptors, Estrogen; D012722:Sewage; D013629:Tamoxifen; D004958:Estradiol